Cagrilintide is a novel peptide compound that has shown promising results in weight management research. As a long-acting GLP-1 receptor agonist, it mimics the effects of natural GLP-1 to support metabolic function.
The peptide works through multiple mechanisms: enhancing glucose-dependent insulin secretion, inhibiting glucagon production, slowing gastric emptying, and promoting satiety through central appetite regulation. These combined effects make it particularly interesting for metabolic research applications.
Our Cagrilintide peptide powder is provided in lyophilized form with >99% purity as verified by HPLC analysis. The white freeze-dried powder maintains excellent stability when stored properly in cool, dry conditions.
Key research applications include:
1. Metabolic syndrome studies
2. Weight management mechanisms
3. Glucose regulation research
4. Appetite control investigations
The peptide's extended half-life makes it particularly suitable for chronic study models. Researchers have noted its potential benefits beyond simple weight management, including possible cardiovascular and lipid profile improvements.
This product is intended for laboratory research use only. Proper handling procedures should be followed when working with peptide compounds.